Last synced on 12 October 2025 at 8:21 pm

Transdermal Test For Assessment Of Glomerular Filtration Rate

Page Type
Product Code
Definition
A test used to assess a patient’s glomerular filtration rate (GFR) by injecting a fluorescent tracer molecule into the blood stream and measuring the amount of fluorescence through the skin with a transdermal sensor.
Physical State
The test system may include sensors, software, a monitor, and a molecular tracer agent which is injected into the patient.
Technical Method
A tracer is injected into a patient’s blood stream and a sensor is used to measure the tracer signal from the blood through the patient’s skin. This signal is converted to a glomerular filtration rate.
Target Area
Kidney or Renal
Review Panel
Gastroenterology and Urology
Submission Type
PMA
Device Classification
Class 3
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

The FDA has not linked product code SDK to any particular section of the CFR (Code of Federal Regulations). There are multiple reasons why this might be the case:

  • The product code was created for a class III submission that does not follow the normal PMN or PMA path - e.g., for a device that falls under HDE (Humanitarian Device Exemption) or EUA (Emergency Use Authorization).
  • The FDA has generated the product code for an existing Class III device, as a result of a PMA supplement that modifies the device in a way that it can't fit under the existing product code originally assigned
  • The product code was created for internal use at the FDA, and not for classification or regulatory-related purposes.

Transdermal Test For Assessment Of Glomerular Filtration Rate

Page Type
Product Code
Definition
A test used to assess a patient’s glomerular filtration rate (GFR) by injecting a fluorescent tracer molecule into the blood stream and measuring the amount of fluorescence through the skin with a transdermal sensor.
Physical State
The test system may include sensors, software, a monitor, and a molecular tracer agent which is injected into the patient.
Technical Method
A tracer is injected into a patient’s blood stream and a sensor is used to measure the tracer signal from the blood through the patient’s skin. This signal is converted to a glomerular filtration rate.
Target Area
Kidney or Renal
Review Panel
Gastroenterology and Urology
Submission Type
PMA
Device Classification
Class 3
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
No
Life-Sustain/Support Device
No
Third Party Review
Not Third Party Eligible

No Linked CFR Text

The FDA has not linked product code SDK to any particular section of the CFR (Code of Federal Regulations). There are multiple reasons why this might be the case:

  • The product code was created for a class III submission that does not follow the normal PMN or PMA path - e.g., for a device that falls under HDE (Humanitarian Device Exemption) or EUA (Emergency Use Authorization).
  • The FDA has generated the product code for an existing Class III device, as a result of a PMA supplement that modifies the device in a way that it can't fit under the existing product code originally assigned
  • The product code was created for internal use at the FDA, and not for classification or regulatory-related purposes.